Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48.
- DOI
- 10.3390/vaccines14050444
- Published
- 2026 May 16
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines14050444,
title = {Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48.},
author = {Fierro C and Brune D and Leggett R and Peterson J and Lorenz B and Calabro Calheiros R and Lin J and Iyer AS and Wu K and Cao X and Kondapally A and Marsh S and Kalidindi S and Husson J and Panther L},
year = {2026},
journal = {Vaccines},
doi = {10.3390/vaccines14050444},
url = {https://doi.org/10.3390/vaccines14050444}
}RIS
TY - JOUR TI - Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48. AU - Fierro C AU - Brune D AU - Leggett R AU - Peterson J AU - Lorenz B AU - Calabro Calheiros R AU - Lin J AU - Iyer AS AU - Wu K AU - Cao X AU - Kondapally A AU - Marsh S AU - Kalidindi S AU - Husson J AU - Panther L PY - 2026 JO - Vaccines DO - 10.3390/vaccines14050444 UR - https://doi.org/10.3390/vaccines14050444 ER -
APA
C, F., D, B., R, L., J, P., B, L., R, C. C., J, L., AS, I., K, W., X, C., A, K., S, M., S, K., J, H., & L, P. (2026). Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48.. Vaccines. https://doi.org/10.3390/vaccines14050444
Source records
- pubmed · retrieved 2026-09-26T01:46:49.023Z